本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

15.84
+0.61004.01%
盘前16.100.2600+1.64%05:31 EST
成交量:59.44万
成交额:944.19万
市值:8.01亿
市盈率:-4.01
高:16.13
开:15.32
低:15.13
收:15.23
52周最高:17.30
52周最低:7.30
股本:5,054.63万
流通股本:2,781.23万
量比:0.47
换手率:2.14%
股息:- -
股息率:- -
每股收益(TTM):-3.9460
每股收益(LYR):-3.6945
净资产收益率:-190.18%
总资产收益率:-60.98%
市净率:19.63
市盈率(LYR):-4.29

数据加载中...

2024/04/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/29

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]